Cimetidine, 800 mg at night, in the treatment of duodenal ulcers. 1985

S Kildebo, and O Aronsen, and B Bernersen, and R Breckan, and A Gjellestad, and K Johnsen, and A Sandvik

One hundred and eight patients with endoscopically proven duodenal ulcers were randomly allocated to treatment with cimetidine, either 400 mg twice daily or 800 mg at night for 4 to 8 weeks in a double-blind study. There was no significant difference between the healing rates of the two groups. Thus, 45 of 52 (87%) healed on cimetidine twice daily and 43 of 51 (84%) healed on 800 mg at night after 4 weeks' treatment. The corresponding healing rates after 8 weeks were 51 of 52 (98%) and 50 of 51 (98%). The intensity of pain decreased more rapidly in the group treated with 800 mg cimetidine at night. These results indicate that 800 mg cimetidine at night is as good as 400 mg given twice daily.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004381 Duodenal Ulcer A PEPTIC ULCER located in the DUODENUM. Curling's Ulcer,Curling Ulcer,Curlings Ulcer,Duodenal Ulcers,Ulcer, Curling,Ulcer, Duodenal,Ulcers, Duodenal
D005260 Female Females

Related Publications

S Kildebo, and O Aronsen, and B Bernersen, and R Breckan, and A Gjellestad, and K Johnsen, and A Sandvik
January 1986, Scandinavian journal of gastroenterology. Supplement,
S Kildebo, and O Aronsen, and B Bernersen, and R Breckan, and A Gjellestad, and K Johnsen, and A Sandvik
October 1989, Alimentary pharmacology & therapeutics,
S Kildebo, and O Aronsen, and B Bernersen, and R Breckan, and A Gjellestad, and K Johnsen, and A Sandvik
April 1986, Wiener klinische Wochenschrift,
S Kildebo, and O Aronsen, and B Bernersen, and R Breckan, and A Gjellestad, and K Johnsen, and A Sandvik
August 1986, The British journal of clinical practice,
S Kildebo, and O Aronsen, and B Bernersen, and R Breckan, and A Gjellestad, and K Johnsen, and A Sandvik
November 1984, British medical journal (Clinical research ed.),
S Kildebo, and O Aronsen, and B Bernersen, and R Breckan, and A Gjellestad, and K Johnsen, and A Sandvik
October 1977, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
S Kildebo, and O Aronsen, and B Bernersen, and R Breckan, and A Gjellestad, and K Johnsen, and A Sandvik
January 1988, Digestion,
S Kildebo, and O Aronsen, and B Bernersen, and R Breckan, and A Gjellestad, and K Johnsen, and A Sandvik
January 1990, Journal of clinical gastroenterology,
S Kildebo, and O Aronsen, and B Bernersen, and R Breckan, and A Gjellestad, and K Johnsen, and A Sandvik
February 1981, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
S Kildebo, and O Aronsen, and B Bernersen, and R Breckan, and A Gjellestad, and K Johnsen, and A Sandvik
March 1991, Annals of the Academy of Medicine, Singapore,
Copied contents to your clipboard!